human trials bpc 157 bpc-157 clinical evidence review safety regulatory status BPC-157 bpc-157 human clinical trials evidence
Description
CEN Case Reports
Luteal phase HCG support for unexplained recurrent pregnancy loss a low hanging fruit
Jose Manuel Garcia Garcia and Valentina Vannuzzi equally contributed to the work
HPLC purity greater than 98 percent for both BPC-157 and TB-500 components, ideally above 99 percent for sensitive research applications
Nevertheless, the underlying mechanisms by which NNMT regulates SIRT1 require further investigation and so does whether NNMT alters the activity of other sirtuins
Read more Apr 18 BPC-157 vs TB-500 - Research Applications Compared A research-context comparison of BPC-157 and TB-500
